MLI Education

Directions Website

MLI Education Where education meets Innovation. Jointly Accredited with Commendation.

What happens when pediatric IBS-C patients transition to adult care?Hear expert insights on evidence-based strategies fo...
10/07/2026

What happens when pediatric IBS-C patients transition to adult care?
Hear expert insights on evidence-based strategies for treatment selection, monitoring, and seamless transitions of care in this 🆕 on-demand CME course. Earn credit for free👉mli.link/ibs-c

Better obesity care starts with a stronger playbook. Explore evidence-based approaches to diagnosis, individualized trea...
10/05/2026

Better obesity care starts with a stronger playbook.

Explore evidence-based approaches to diagnosis, individualized treatment, patient engagement, and long-term management in this NEW on-demand CME course for primary care clinicians.

Get started & earn credit for free 👉 mli.link/pcpob

Heading to the Big Easy for ? Join us for a free CME breakfast symposium on Saturday 10/10 & be part of an interactive,...
09/30/2026

Heading to the Big Easy for ? Join us for a free CME breakfast symposium on Saturday 10/10 & be part of an interactive, expert-led discussion on DME! Save your spot: mli.link/dme-reg

🗓️ Saturday, 10/10 | 7-8 AM CDT
📍 Le Méridian New Orleans | Esplanade Ballroom 1/2
💻 Livestream available!

09/20/2026

Avoiding a drug your patients with myeloma need out of concerns about a side effect you already know how to manage? Dr. Saad Usmani discusses managing neutropenia w/ CELMoD-containing regimens in this reelCE episode.

See the full series & get CE credit at reelCE.com

09/19/2026

95% overall response rates in patients with who'd already had 2-4 lines of therapy? Dr. Saad Usmani digs into the data for CELMoDs with bispecifics in this reelCE episode.

Watch the full series & get CE credit at reelCE.com

09/13/2026

We all love CAR-T therapy in , but cure rates aren't yet 100%. Dr. Banerjee discusses strategies for making the CAR-T "honeymoon" last longer for your patients in this reelCE episode.

Watch the full series & get CE credit at reelCE.com.

09/07/2026

Daratumumab finds its targets better when CELMoDs have already been there. Dr. Saad Usmani shares insights on combining CELMoDs with backbone agents to treat patients with in this reelCE episode

Watch the full series & claim CE credit at reelCE.com

09/06/2026

The Successor-2 trial data released this year showed half the progression of multiple myeloma using half the dose of a drug you still use. Dr. Banerjee reviews the data in this reelCE episode.

Watch the rest of the series & get CE credit at reelCE.com

09/05/2026

The FDA approved a new drug - iberdomide - to treat multiple myeloma on August 13, 2026. In this reelCE episode, Dr. Khan dives into its combinations in , and what the data means for oncologists.

Watch the full series & claim CE credit at reelCE.com

09/02/2026

Think IMiD resistance is inevitable in patients with multiple myeloma? Dr. Saad Usmani shares how CELMoDs might change that in this reelCE episode.

Watch the full series & claim CE credit at reelCE.com

Address

40946 US Highway 19N, #602
Tarpon Springs, FL
34689

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Website

Alerts

Be the first to know and let us send you an email when MLI Education posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category